Ethanolamine is deaminated by the action of ethanolamine ammonia-lyase (EC 4.3.1.7), an adenosylcobalamin-dependent enzyme. Consequently, to grow on ethanolamine as a sole nitrogen source, Bacillus megaterium requires vitamin B12. Identification of B. megaterium mutants deficient for growth on ethanolamine as the sole nitrogen source yielded a total of 34 vitamin Bi2 auxotrophs. The vitamin B12 auxotrophs were divided into two major phenotypic groups: Cob mutants, which could use cobinamide or vitamin B12 to grow on ethanolamine, and Cbl mutants, which could be supplemented only by vitamin B12. The Cob mutants were resolved into six classes and the Cbl mutants were resolved into three, based on the spectrum of cobalt-labeled corrinoid compounds which they accumulated. Although some radiolabeled cobalamin was detected in the wild type, little or none was evident in the auxotrophs. The results indicate that Cob mutants contain lesions in biosynthetic steps before the synthesis of combinamide, while Cbl mutants are defective in the conversion of cobinamide to cobalamin. Analysis of phage-mediated transduction experiments revealed tight genetic linkage within the Cob class and within the Cbl class. Similar transduction analysis indicated the Cob and Cbl classes are weakly linked. In addition, cross-feeding experiments in which extracts prepared from mutants were examined for their effect on growth of various other mutants allowed a partial ordering of mutations within the cobalamin biosynthetic pathway.
The basic corrin ring structure (cobyrinic acid; Fig. 1 ) which. gives rise to vitamin B12 is biosynthetically derived from utoporphyrinogen III (also a precursor to heme and siroheme) by a series of reductive methylations, a decarboxylation at C-12, ring scission between C-19 and C-20, and insertion of cobalt ( Fig. 1) . Although it is. known that four melthylations of the uroporphyrinogen III ring probably occur first in the biosynthesis of cobalamin, the order of further steps in cobyrinic acid formation is not known. Beyond cobyrinic acid there are six aniidations of carboxyl side groups and an addition of aminopropanol (biosynthetically derived from threonine) to yield cobinamide. Cobinamide is phosphorylated by ATP to yield cobinamide P04, which reacts with GTP to yield GDPcobinamide. GMP is displaced by the 5' nucleotide of dimethylbenzimidazole (DMBI; biosynthetically derived from riboflavin) to produce cobalamin P04, which is dephosphorylated to yield cobalamin (vitamin B12). Adenylation of the corrin macrocycle, which is necessary for the formation of the cofactor form of cobalamin (adenosylcobalamin; also known as coenzyme B12), may occur very early in the biosynthetic sequence but can occur after the formation of cobalamin. For more detailed description of the cobalamin biosynthetic pathway, the reader is referred to recent reviews (2, 11, 13) . The correlation of a particular biosynthetic step with a particular enzyme has not been accomplished. With the possible exception of thb partiai purification of an enzyme(s) involved with the methylation of uroporphyrinogen III, none of the biosynthetic enzymes has been well characterized (17) . Thus, knowledge of enzymology is insufficient even to conclude how many enzymes are * Corresponding author. involved with cobalmin biosynthesis. Virtually nothing is known about the genetic control of this pathway.
To begin a genetic study of a complex biosynthetic pathway, it is first desirable to establish conditions under which an organism requires the pathway end product for growth. A logical way to approach a study of cobalamin biosynthesis is to take advantage of the microbial enzymes that are known to require either methylcobalamin or adenosylcobalamin to act, forcing an organism to utilize a substrate whose metabolism is strictly dependent on vitamin B12. There are a number of such enzymes known (1) . Ethanolamine ammonia-lyase (EC 4.3.1.7) catalyzes the deamination of ethanolamine to acetaldehyde and ammonia (1, 16) . Bradbeer first discovered this reaction in a choline-fermenting Clostridium sp. and demonstrated that the enzyme required adenosylcobalamin (6, 7) . Subsequently, this enzyme has been detected in a number of bacterial species, including Klebsiella aerogenes, Escherichia coli, and Salmonella typhimurium, in which exogenous vitamin B12 is required for growth on ethanolamine (3-5, 10, 19) .
Ethanolamine ammonia-lyase is also present in Bacillus megaterium, an obligate aerobe which is capable of vitamin B12 synthesis under aerobic growth conditions. B. megaterium can use ethanolamine as a sole source of nitrogen. Growth of B. megaterium on ethanolamine, but not on ammonia, is inhibited by adeninylalkyl analogs (12, 18) Bioassay for vitamin B12. To determine the amount of vitamin B12 produced by a particular strain, the appropriate B. megaterium strains were cultured in 50 ml of minimal ammonia medium until they had reached a density of approximately 7 x 107 cells per ml. The cells were harvested, washed twice in 100 mM potassium phosphate (pH 7.0), and resuspended in a final volume of 2 ml in the same buffer and boiled for 20 min to release vitamin B12 (and other corrinoid compounds). Portions (20 ,u) (Fig. 3) . Three of these mutants were designated Cbl X, two were designated Cbl XI, and one was designated Cbl XII. Two of the Cbl mutants accumulated a 57Co-labeled compound which migrated on a thin-layer chromatogram in a manner identical to that of cobinamide. Cbl mutants also accumulated labeled compounds which had mobilities identical with compounds that accumulated in some of the Cob mutants. (Fig. 2) ; three different patterns were observed in the Cbl mutants, and these were designated Cbl X, XI, and XII (Fig. 3) affected by some of the Cob and Cbl mutants by crossfeeding experiments in which extracts prepared from the mutants strains were tested in all possible combinations for the ability to support growth ( Table 3 ). The results were that extracts prepared from each of the Cbl mutants were capable of forming compounds which supplemented each of the mutants of the Cob phenotype. None of the extracts prepared from the Cob mutants was capable of supporting growth of any of the Cbl mutants. Because the extracts of GX5157 (Cbl X) was capable of feeding both GX5160 (Cbl XI) and GX5134 (Cbl XII), the lesion in GX5157 may likely occur in a biosynthetic step(s) after steps determined by lesions in GX5160 and GX5143. Further support for this order is evidenced by the fact that extracts prepared from neither GX5143 nor GX5160 could support the growth of GX5157.
Within the Cob phenotypic grouping, each of the members of the Cob II class, typified by GX5141, was capable of supporting growth of all other mutants of the Cob phenotype, indicating a biosynthetic lesion(s) possibly just before the synthesis of cobinamide. Extracts prepared from mutants of the Cob III, IV, V, and VI classes were incapable of cross-feeding each of the others of those classes, but extracts of each of those supported the growth of some of the Cob I mutants, exemplified by GX5139. Of 10 mutants of the Cob I phenotype, 2 (e.g., GX5101) failed to be supplemented by extracts of Cob III, IV, V, or VI mutants, while the remaining 8 behaved identically with GX5139 (data not shown). The failure of extracts of Cob III, IV, V, and VI mutants to feed GX5101 indicated that the effect of the cob-i mutation might be pleiotropic or that GX5101 harbors multiple mutations. As expected, none of the extracts from the 10 Cob I strains could support the growth of Cob II, III, IV, V, or VI mutants. Further, none of the Cob I mutants was capable of cross-feeding any of the other Cob I mutants. The results of the cross-feeding experiments permitted the ordering of mutations or mutant classes (Fig. 4) .
Transductional linkage of Cob and Cbl mutations. To determine whether the mutations that define the Cob and Cbl mutants are genetically linked, reciprocal two-factor transductional crosses were performed on representative strains of several of the Cob and Cbl subclasses. The transductions were performed with the B. megaterium generalized transducing bacteriophage MP13 (21) . Phage lysates prepared from five of the Cob strains and from three of the Cbl strains were tested in all possible combinations for the ability to transduce recipient strains to vitamin B12 independence on ethanolamine. The Cob I mutants having the phenotype of GX5139 were not included in this analysis. The results of the reciprocal crosses are shown in Table 4 . In general, a low number of prototrophic recombinants indicated the probability of few crossovers between defective allele(s) and, hence, tight linkage between markers. Because reversion of each of the recipient strains was less than 0.33 x 107, values which are low but not background might indicate some crossing over between markers or multiple mutations in some of the strains. These data suggest that the mutations fall into two linkage groups in that those mutations that characterize the Cob class form one linkage group and the mutations that characterize the Cbl class form another. In independent experiments with GX5141 (Cob II) in two factor crosses, weak linkage between cob-41 and the other cob and cbl loci was inferred, suggesting that the Cob II phenotype belongs in yet another linkage group (data not shown).
To determine whether the Cob group is linked to the Cbl group, Cbl-strains were transduced to growth on ethanolamine in the presence of cobinamide with phage lysates prepared from Cob-strains. Cbl+ transductants were then scored for inheritance of the defective Cob allele by growth on ethanolamine in the absence of cobinamide or vitamin B12. Only several Cob-colonies were detected when each of the Cob mutants was transduced into each of the Cbl (Table 5 ). This result indicates a weak linkage between the two mutant classes.
DISCUSSION
The work that we have reported in this paper should provide a rational framework for further studies in cobalamin biosynthesis and regulation. The biosynthetic pathway for cobalamin surely involves the construction of the most complex biological molecules other than proteins and involves an unknown number of gene products, the method of regulation of which is also unknown. The isolation of mutants provides a first discreet step in understanding genetic regulation of cobalamin biosynthesis in an aerobic organism in which regulation of trace quantity synthesis of vitamin B12 might have evolved differently from the pathway in facultative organisms. The isolation of mutants will eventually permit the correlation of a particular enzyme with a defined biosynthetic conversion and will facilitate the cloning and further definition of the genes.
The mutations that result in the Cob or Cbl phenotypes cannot be assigned to defects in any known biosynthetic enzymes. However, some genetic defects could be assigned to narrow regions of the cobalamin biosynthetic pathway based on the combined results of cross-feeding and cobaltlabeling experiments. For example, mutants of the Cob I class did not accumulate any cobalt-containing corrinoids; hence, some of those mutants were probably defective in the conversion of sirohydrochlorin to cobyrinic acid, at points before the insertion of cobalt into the ring structure. Because none of the Cob I mutants required reduced sulfur for growth they must be able to synthesize sirohydrochlorin and hence siroheme, the prosthetic group for sulfite and nitrite reductases (14, 20; Fig. 1 ). The exact point at which cobalt is inserted into the ring structure is unknown. Thus, members of the Cob I class could be deficient in any of a number of biosynthetic steps in the conversion of sirohydrochlorin to cobyrinic acid. Cobalt insertion could occur at any point in that series of steps, possibly by enzymatic means; it could also occur nonspecifically or nonenzymatically at multiple points. Failure to accumulate cobalt ion could also result in the inability to synthesize cobalt-containing compounds. Among the 20 Cob mutants, six different cobalt-labeling patterns were obtained; three different patterns were obtained in the Cbl mutants. An interpretation for these results is that lesions in particular biosynthetic enzymes, presumably caused by mutations in separate genes, caused accumulation of pathway intermediates before the lesions. Each of the 57Co-labeled compounds could be intermediates in the cobalamin pathway, but some of the compounds could be side products.
Biosynthetic defects present in Cob II, III, IV, V, and VI mutants must occur at points after the insertion of cobalt and, thus, after those of the Cob I mutants. Defects in the five Cob II mutants could be positioned after the biosynthetic defects of the Cob III, IV, V, and VI mutants because extracts prepared from Cob II mutants were able to feed all other Cob mutants. The Cob III, IV, V, and VI mutants formed a group in that none of those four mutants could cross-feed each other. This grouping of mutants was positioned as it was in Fig. 4 because extracts prepared from each of those strains could feed 8 of 10 Cob I mutants. This result indicated that the Cob I class consisted of two subclasses; it also indicated that at least one compound present in each of the extracts of Cob III, IV, V, and VI mutants could be taken up by GX5139 and other Cob I mutants of its ilk, suggesting that a failure of those mutants to cross-feed each other was not due to impermeability of those corrinoids.
At least one compound present in extracts of Cob III, IV, V, and VI mutants can be converted into cobalamin in vivo by Cob I mutants similar to GX5139, bypassing the Cob I biosynthetic defects, whereas Cob I mutants similar to GX5101 cannot convert those compounds into cobalamin. This suggests that the cob-i mutation(s) may affect a number of biosynthetic steps in that GX5101 does not synthesize cobalt-containing corrinoids and also behaves as though it were a member of the Cob III, IV, V, and VI group.
Combined results of cobalt-labeling and' cross-feeding experiments revealed that most of the mutants which were incapable of growth on ethanolamire failed to synthesize cobalamin. However, one particular mutant, GX5134 (Cob V), synthesized a compound which migrated identically with cobalamin and formed bioactive vitamin at 20% the level of the wild type, yet this strain required exogenous vitamin B12 for growth on ethanolamine. The material from GX5134 which migrated as cobalamin may not be authentic cobalamin and may differ also in its ability to serve as a cofactor for ethanolamine ammonia-lyase. If the compound is authentic vitamin B12, the rate of its biosynthesis in the mutant may be much lower than in the wild type, resulting in levels of cobalamin in the mutant that are too low to act as cofactor during logarithmic growth on ethanolamine. The cob-37, cob-34, cob-SI, cob-27, and cob-i mutations appeared to be genetically linked, based on transduction data. However, in the absence of suitable outside genetic markers, quantitative transduction could only point to trends in linkage; actual linkage between markers or their order could not be determined. The trend in the linkage data indicated that the cbl-43, cbl-57, and cbl-60 alleles were linked to each other and not tightly to other mapped cob alleles.
The major corrinoid compound that accumulated in wildtype cells was cobalamin; none of the cobalt-labeled intermediates that accumulated in the Cob or Cbl class mutants was detectable in the wild type. Loss of vitamin B12 biosynthesis in some of the Cbl mutants sometimes resulted in a two-to threefold increase over the wild-type levels of corrinoids which could support growth of an S. typhimurium indicator strain, suggesting that cobalamin or a closely related compound is involved in regulation of the pathway. Points at which some compounds accumulated in the mutants may suggest which steps are rate limiting in biosynthesis.
An obvious strategy for overcoming the regulation of rate-limiting steps is to increase the gene dosage of the rate-limiting enzymes by cloning. Recent experiments suggest that some of the auxotrophs can be used to isolate DNA fragments that complement the mutations (unpublished data). Given the apparently tight genetic linkage between mutations that characterize the Cob mutants and the Cbl mutants, a relative small number of cloned fragments could encompass many of the biosynthetic genes. Hence, this approach could lead to a better understanding of the regulation of a biosynthetic pathway which is composed of perhaps 20 or more enzymes and genes that encode them.
